Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Main Capital and Björn Lundén in connection with the acquisition of Aprello
Mandate

Vinge advises Main Capital and Björn Lundén in connection with the acquisition of Aprello

January 30, 2025

Vinge has advised Björn Lundén, a provider of accounting and financial administration software, in connection with the acquisition of Aprello AB (“Aprello”). The strategic acquisition complements Björn Lundén’s growth strategy in the European financial administration software market.

Aprello, founded in 2017, specializes in the development of software solutions for annual reporting and tax submissions, serving both tax and accountancy firms as well as SMEs in Sweden. Aprello focuses on user-friendly solutions and offers features such as smart templates, digital management reports, e-signing, and step-by-step guidance.

Vinge’s team consisted of Filip Öhrner, Maria Dahlin Kolvik, Alexander Rüdén (M&A), Martin Boström (GDPR) and Felizia Wiker (Intellectual Property).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026